1058 GMT January 22, 2020
It will first be trialed on lung cancer, but experts say it will be able to detect a range of cancers as well as other diseases, including TB and dementia, express.co.uk reported.
The first trials are to be carried out this autumn in two NHS hospitals and at two in the US.
If the first human trials prove successful scientists at ANCON Medical, which is behind the technology, said the kits could be on the market within two years.
Glyn Hiatt-Gipson, who has helped develop the technology, said, "This is more sensitive than the nose of a dog and is powered by AI so is constantly evolving.
"My vision is that within a decade patients will be able to breath into this mouthpiece and doctors will be able to diagnose as many as 400 different diseases in just one breath."